Stocks / NASDAQ / LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc.

Our Opinion

LeMaitre Vascular, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, services, research and therapies.

Supporting Evidence:

The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.

“Our products are subject to our design control procedures throughout the various stages of product development. These procedures may include bench¬†testing, animal testing, human use testing conducted by independent physicians, and post-market surveillance of product performance, as appropriate.” (Page 11) Read the following document

Company Description

LeMaitre Vascular, Inc. is a medical device company, which provides medical devices for the treatment of peripheral vascular disease. The company design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA. [Source: MarketWatch]

Company Website: http://www.lemaitre.com